August 21, 2018
Fitch Even partner Kendrew H. Colton is quoted in an article published in the August 19, 2018 issue of Chemical & Engineering News, a weekly publication of the American Chemical Society.
The article, titled "Firms Feud Over Niagen, A Purported Age-Fighting Molecule," discusses the ongoing patent dispute between ChromaDex and Elysium Health over rights to nicotinamide riboside or NR, a molecule with promising vitamin-like qualities.
Ken has been practicing intellectual property law for over 30 years. His primary practice focus is counseling clients on a wide range of IP matters involving established and emerging chemical and biochemical technologies. Ken has been a member of the Chemical & Engineering News Advisory Board since 2012.
- Fitch Even Partner Tom Lebens to Copresent AIPLA Webinar on Trade SecretsJuly 6, 2020 Read more
IP Alert | USPTO Launches Fast-Track Appeals Pilot Program TodayJuly 2, 2020
The USPTO has announced that beginning today the PTAB will begin accepting petitions for expedited resolution of ex parte appeals under the newly launched Fast-Track Appeals Pilot Program. Read more